211 related articles for article (PubMed ID: 10081351)
1. [HTLV examination of Norwegian blood donors].
Samdal HH; Skaug K; Stigum H; Hervig T; Kjeldsen-Kragh J; Skar AG
Tidsskr Nor Laegeforen; 1999 Jan; 119(2):206-8. PubMed ID: 10081351
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model.
Stigum H; Magnus P; Samdal HH; Nord E
Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551
[TBL] [Abstract][Full Text] [Related]
3. Human T-lymphotropic virus and transfusion safety: does one size fit all?
Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Piccinini V; Liumbruno GM; Grazzini G
Transfusion; 2016 Jan; 56(1):249-60. PubMed ID: 26388300
[TBL] [Abstract][Full Text] [Related]
4. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
[TBL] [Abstract][Full Text] [Related]
5. The clinical relevance of HTLV type I and II in transfusion medicine.
Vrielink H; Zaaijer HL; Reesink HW
Transfus Med Rev; 1997 Jul; 11(3):173-9. PubMed ID: 9243770
[No Abstract] [Full Text] [Related]
6. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group.
Sullivan MT; Williams AE; Fang CT; Grandinetti T; Poiesz BJ; Ehrlich GD
Arch Intern Med; 1991 Oct; 151(10):2043-8. PubMed ID: 1929693
[TBL] [Abstract][Full Text] [Related]
7. [Infection with T-lymphotropic virus in Dutch blood donors, 1993-1996].
Zaaijer HL; Lelie PN; van der Poel CL
Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1571-2. PubMed ID: 9543753
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999.
Lu SC; Kao CL; Chin LT; Chen JW; Yang CM; Chang JH; Hsu SC; Chang AC; Chen BH
Int J Hematol; 2001 Oct; 74(3):333-7. PubMed ID: 11721972
[TBL] [Abstract][Full Text] [Related]
9. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
Murphy EL
Transfus Clin Biol; 2016 Feb; 23(1):13-9. PubMed ID: 26778839
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil.
Ferreira Júnior OC; Vaz RS; Carvalho MB; Guerra C; Fabron AL; Rosemblit J; Hamerschlak N
Transfusion; 1995 Mar; 35(3):258-63. PubMed ID: 7878720
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell lymphotropic virus type I and II in transfusion medicine.
Sandler SG; Fang CT; Williams AE
Transfus Med Rev; 1991 Apr; 5(2):93-107. PubMed ID: 1687974
[TBL] [Abstract][Full Text] [Related]
12. [Quality adjusted life years in assessment of preventive measures. Should blood donors be tested for HTLV-I/II infections?].
Magnus P; Stigum H; Nord E; Bjørndal A; Samdal HH; Skulberg A; Heier HE
Tidsskr Nor Laegeforen; 1996 Apr; 116(10):1229-32. PubMed ID: 8658396
[TBL] [Abstract][Full Text] [Related]
13. [HTLV-I AND HTLV-II in Spain].
An Med Interna; 1995 Jun; 12(6):299-306. PubMed ID: 7548650
[TBL] [Abstract][Full Text] [Related]
14. HTLV infection in England and Wales in 2002--results from an enhanced national surveillance system.
Dougan S; Payne LJ; Tosswill JH; Davison K; Evans BG
Commun Dis Public Health; 2004 Sep; 7(3):207-11. PubMed ID: 15481214
[TBL] [Abstract][Full Text] [Related]
15. HTLV-I and HTLV-II infections in French blood donors.
Couroucé AM; Pillonel J; Lemaire JM
Vox Sang; 1993; 65(4):334. PubMed ID: 8310688
[No Abstract] [Full Text] [Related]
16. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
[TBL] [Abstract][Full Text] [Related]
17. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.
Lee HH; Swanson P; Rosenblatt JD; Chen IS; Sherwood WC; Smith DE; Tegtmeier GE; Fernando LP; Fang CT; Osame M
Lancet; 1991 Jun; 337(8755):1435-9. PubMed ID: 1675317
[TBL] [Abstract][Full Text] [Related]
18. Blood safety strategies for human T-cell lymphotropic virus in Europe.
Laperche S; Worms B; Pillonel J; ;
Vox Sang; 2009 Feb; 96(2):104-10. PubMed ID: 19076337
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
20. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
